NCT05883605

Brief Summary

Clinical validation of the wrist blood pressure measuring device Combei BP 880 W for home use according to "the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO)" in the general population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P25-P50 for not_applicable hypertension

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

January 10, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2023

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 27, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 1, 2023

Completed
Last Updated

June 1, 2023

Status Verified

May 1, 2023

Enrollment Period

4 months

First QC Date

May 31, 2022

Last Update Submit

May 29, 2023

Conditions

Keywords

validationBlood pressure.wrist deviceelectronic BP devicehome Blood pressure

Outcome Measures

Primary Outcomes (1)

  • Accuracy of blood pressure measurement

    differences \< than 5 +/- 8 mmHg according to the protocol by comparison to the gold standard (mercury sphygmomanometer)

    Subject will participate to only one session of measurement. The duration of one session is about 45 minutes.

Secondary Outcomes (1)

  • differences between the tested device and the gold standard (mercury sphygmomanometer according to the baseline blood pressure and to the wrist circumference

    Subject will participate only one time to the study. one session of blood pressure measurement will be performed. the duration of one session is about 45 minutes

Study Arms (1)

one population of normotensive and hypertensive

OTHER

treated and untreated normotensive and hypertensive patients

Device: Measuring blood pressure

Interventions

Measuring blood pressure using electronic device and using a mercury sphygmomanometer

one population of normotensive and hypertensive

Eligibility Criteria

Age18 Years - 80 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsMinimunn 30% male or female
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient older than 12 years;
  • Patient who signed the informed consent form;
  • Patient followed-up at site (in-patient or out-patient);
  • Patient with wrist circumference between 12.5 and 21.5 cm\*. \*in accordance with the Indications For Use of the Combei BP 880 W device.

You may not qualify if:

  • Patient unable to give a consent or understand properly protocol information;
  • Patient suffering from arrhythmia;
  • Patient with poor quality of Korotkov sounds;
  • Patient for whom K5 sounds are absent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Roland Asmar

Paris, 75016, France

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • ROLAND ASMAR

    International Society of Vascular Health

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Roland Asmar

Study Record Dates

First Submitted

May 31, 2022

First Posted

June 1, 2023

Study Start

January 10, 2023

Primary Completion

May 23, 2023

Study Completion

May 27, 2023

Last Updated

June 1, 2023

Record last verified: 2023-05

Locations